Superiority of bivalirudin over heparin anticoagulation therapy for extracorporeal membrane oxygenation? Too early to draw conclusions

BACKGROUND: We aimed to compare the efficacy and safety of bivalirudin versus heparin as the anticoagulant in patients undergoing extracorporeal membrane oxygenation (ECMO). METHODS: We conducted a search in PubMed, Embase and the Cochrane Library for all the studies in which bivalirudin was compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Jie, Yu, Hongjie, Lin, Dang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970897/
https://www.ncbi.nlm.nih.gov/pubmed/36865472
http://dx.doi.org/10.1016/j.heliyon.2023.e13530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970897/
https://www.ncbi.nlm.nih.gov/pubmed/36865472
http://dx.doi.org/10.1016/j.heliyon.2023.e13530

Ejemplares similares